Riskpilot← Back to searchSign inGet full accessEMOGEM AS
ASActiveOrg 913659066Salheimsveien 14A, 9603 HammerfestBusiness and other management consultancy activities · NACE 7020Est. 20140 employees
Revenue 2025
NOK 601K
EBITDA margin
-6.9%
+94% vs 2024
Equity ratio
-3574.3%
Financial strength
Net profit 2025
NOK -72K
+92% vs 2024
| Revenue | NOK 601K | — |
| EBITDA | NOK -42K | +94% |
| Net profit | NOK -72K | +92% |
| Total assets | NOK 25K | -22% |
| Equity | NOK -888K | -9% |
| Employees | 0 | — |
Legal name
EMOGEM AS
Org number
913659066
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
20. mai 2014
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie og forvalte fast eiendom og aksjer og andeler i selskaper og virksomheter, finansiering av andre selskaper og virksomheter, og dertil hørende virksomhet.
Address
Salheimsveien 14A, 9603 Hammerfest
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 74 | 0 | 0 | 601 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −338 |
| EBITDA | −5 | −6 | −7 | −7 | −5 | −6 | −8 | 23 | 65 | −14 | −754 | −42 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 | −6 | −7 | −7 | −5 | −6 | −8 | 23 | 65 | −14 | −754 | −42 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | −98 | −30 |
| Profit before tax | −5 | −6 | −7 | −7 | −5 | −6 | −8 | 23 | 65 | −14 | −853 | −72 |
| Tax | −3 | −0 | 4 | −0 | −0 | −1 | −0 | −0 | 17 | −3 | 3 | −0 |
| Net profit | −2 | −6 | −11 | −7 | −5 | −5 | −8 | 23 | 48 | −11 | −856 | −72 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 23 | 23 | 20 | 19 | 81 | 167 | 317 | 407 | 474 | 770 | 32 | 25 |
| Equity | 22 | 17 | 5 | −1 | −7 | −12 | −20 | 3 | 51 | 40 | −816 | −888 |
| Long-term debt | 0 | 5 | 13 | 19 | 88 | 179 | 337 | 396 | 396 | 716 | 848 | 808 |
| Short-term debt | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 8 | 27 | 14 | 0 | 105 |
| Total debt | 1 | 6 | 15 | 20 | 88 | 179 | 337 | 404 | 423 | 730 | 848 | 913 |
EBITDA margin
-6.9%
This company
15.8%
Market median
-144% vs market
20142025
Equity ratio
-3574.3%
This company
38.2%
Market median
-9457% vs market
20142025
Return on equity
-7179200.0%
This company
18.4%
Market median
-39017491% vs market
20142025
Net profit margin
-11.9%
This company
8.1%
Market median
-247% vs market
20142025
Asset turnover
24.21×
This company
1.12×
Market median
+2062% vs market
20142025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20142025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EMOGEM AS 
KINEVO ASBoard members of EMOGEM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Tore Kvalnes | Chairman | 0 companies |